Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SNDX
#1702
Syndax Pharmaceuticals, Inc.
21.7
1
+6.89%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+6.89%
Changement Mensuel
+1.92%
Evolution sur 6 mois
+32.54%
Changement Annuel
+43.02%
Clôture Précédente
20.3
1
Open
21.7
1
Bid
Ask
Low
21.7
1
High
21.7
1
Volume
124
Marchés
Actions des Marchés US
Soins de Santé
SNDX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Nouvelles
Stifel, Syndax Pharmaceuticals 목표 주가 상향
Stifel raises Syndax Pharmaceuticals stock price target on drug sales
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2025 Earnings Call Transcript
Syndax 2025년 4분기 실적 발표: 매출 50% 급증, 수익성 경로 제시
Syndax Q4 2025 slides: revenue surges 50%, profitability path outlined
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Syndax Pharmaceuticals Q4 실적 에상치보다 저조, 수익 예상치를 넘어
Syndax Pharmaceuticals earnings missed by $0.19, revenue topped estimates
Syndax, 암 치료제 출시 가속화 속 실적 시험대
Syndax faces earnings test as cancer drug launches accelerate
Syndax, Guggenheim 서밋에서 강력한 성장과 전략적 확장 강조
Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth Into 2026 (NASDAQ:SNDX)